2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... increase to 500 mcg ... eosinophils are low, adding ... won’t have any clinical
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... Skin Disease Classification ... Kikuchi disease • Type-I ... lymphoproliferative syndrome Clinical ... pancreatitis, protein-losing